US Patent Issued to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM on Dec. 16 for "Biomarker for detecting cancer" (Texas Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,498,372, issued on Dec. 16, was assigned to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas).

"Biomarker for detecting cancer" was invented by Robert Bresalier (Houston), Nachman Mazurek (Houston) and James C. Byrd (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for detecting colorectal cancer or precancerous conditions such as adenomatous polyps in a subject by detection of a galactose-containing 40-kDa molecule in a serum sample from the subject are provided. Methods for quantifying the amount of a galactose-containing molecule in a serum sample are also provided. The methods can further comprise assaying the sample for...